Update to adrenaline 150 microgram auto-injector validation protocol – urgent action required by pharmacy teams

Update to adrenaline 150 microgram auto-injector validation protocol – urgent action required by pharmacy teams

November 6, 2018

A revised interim protocol on dispensing adrenaline 150 microgram auto-injectors has been issued by the Department of  Health and Social Care (DHSC).

Stock levels are now sufficient to ensure that – with immediate effect – every patient that presents a prescription will be able to have access to at least two adrenaline auto-injectors that are either in date or have a formally extended expiry date

Supplies may be constrained until the end of the year due to the backlog of patients requiring new devices.

The existing dispenser and wholesaler prescription validation processes will continue for all adrenaline 150 microgram auto-injector prescriptions (private and NHS).

Steps for pharmacies to take:

1. Read the updated protocol from DHSC, noting in particular:

  • The revised flow chart of questions to ask patients to ascertain those who are in most need of supply;
  • The extension to the usability of some batches of Jext 150 and 300 micrograms, previously advised of EpiPen 300 microgram expiry extension; and

2. Read the updated FAQs prepared by DHSC

3. Implement the protocol with immediate effect

Note this advice is interim and will be reviewed and relaxed whenever possible, but remains in force until further notice.

Please see our dedicated adrenaline resource page for all the latest and previous guidance following the adrenaline 150 microgram auto-injector supply disruption.

 



Posted in: ,


More Latest News >

Christmas opening hours

Community pharmacy contractors do not have to open on days which are specifically mentioned in the Regulations (namely Christmas Day,...

FMD webinar now on-demand

Community pharmacy contractors can now access an online recording of PSNC’s recent webinar about the Falsified Medicines Directive (FMD). More than 1,000 people...